Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib + Vinflunine in Advanced Urothelial Carcinoma
NCT01265940Phase 2Completed
- Start
- Mar 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in urothelial carcinoma (UC). Started Mar 2011; status: completed.
02
Drugs
pazopanib
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01265940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265940.